Knee extensor strength exhibits potential to predict function in sporadic inclusion-body myositis

被引:26
作者
Lowes, Linda Pax [1 ]
Alfano, Lindsay [1 ]
Viollet, Laurence [1 ]
Rosales, Xiomara Quintero [1 ,2 ]
Sahenk, Zarife [1 ,2 ]
Kaspar, Brian K. [1 ,2 ]
Clark, K. Reed [1 ]
Flanigan, Kevin M. [1 ,2 ]
Mendell, Jerry R. [1 ,2 ]
McDermott, Michael P. [3 ]
机构
[1] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, Dept Pediat & Neurol, Columbus, OH 43210 USA
[3] Univ Rochester, Sch Med & Dent, Rochester, NY USA
关键词
functional outcomes; maximum voluntary isometric contraction testing; sporadic inclusion-body myositis; strength; prognosis; surrogate measures; DUCHENNE MUSCULAR-DYSTROPHY; RANDOMIZED PILOT TRIAL; CORTICOSTEROID TREATMENT; NATURAL-HISTORY; DOUBLE-BLIND; INTRAVENOUS IMMUNOGLOBULIN; PREDNISONE; PLACEBO; DISEASE; PROGRESSION;
D O I
10.1002/mus.22321
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: In this study we address the challenging issue of potential use of muscle strength to predict function in clinical trials. This has immediate relevance to translational studies that attempt to improve quadriceps strength in sporadic inclusion-body myositis (sIBM). Methods: Maximum voluntary isometric contraction testing as a measure of muscle strength and a battery of functional outcomes were tested in 85 ambulatory subjects with sIBM. Results: Marked quadriceps weakness was noted in all patients. Strength was correlated with distance walked at 2 and 6 minutes. Additional correlations were found with time to get up from a chair, climb stairs, and step up on curbs. Conclusions: Quadriceps (knee extensor) strength correlated with performance in this large cohort of sIBM subjects, which demonstrated its potential to predict function in this disease. These data provide initial support for use of muscle strength as a surrogate for function, although validation in a clinical trial is required. Muscle Nerve, 2012
引用
收藏
页码:163 / 168
页数:6
相关论文
共 33 条
  • [11] INCLUSION-BODY MYOSITIS AND MYOPATHIES
    GRIGGS, RC
    ASKANAS, V
    DIMAURO, S
    ENGEL, A
    KARPATI, G
    MENDELL, JR
    ROWLAND, LP
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (05) : 705 - 713
  • [12] Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors
    Haidet, Amanda M.
    Rizo, Liza
    Handy, Chalonda
    Umapathi, Priya
    Eagle, Amy
    Shilling, Chris
    Boue, Daniel
    Martin, Paul T.
    Sahenk, Zarife
    Mendell, Jerry R.
    Kaspar, Brian K.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (11) : 4318 - 4322
  • [13] Hamstrings to quadriceps peak torque ratios diverge between sexes with increasing isokinetic angular velocity
    Hewett, Timothy E.
    Myer, Gregory D.
    Zazulak, Bohdanna T.
    [J]. JOURNAL OF SCIENCE AND MEDICINE IN SPORT, 2008, 11 (05) : 452 - 459
  • [14] Deflazacort use in Duchenne muscular dystrophy:: An 8-year follow-up
    Houde, Sylvie
    Filiatrault, Michele
    Fournier, Anne
    Dube, Julie
    D'Arcy, Sylvie
    Berube, Denis
    Brousseau, Yves
    Lapierre, Guy
    Vanasse, Michel
    [J]. PEDIATRIC NEUROLOGY, 2008, 38 (03) : 200 - 206
  • [15] Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity
    Jackson, C. E.
    Barohn, R. J.
    Gronseth, G.
    Pandya, S.
    Herbelin, L.
    [J]. MUSCLE & NERVE, 2008, 37 (04) : 473 - 476
  • [16] Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy
    King, W. M.
    Ruttencutter, R.
    Nagaraja, H. N.
    Matkovic, V.
    Landoll, J.
    Hoyle, C.
    Mendell, J. R.
    Kissel, J. T.
    [J]. NEUROLOGY, 2007, 68 (19) : 1607 - 1613
  • [17] Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy
    Kissel, JT
    McDermott, MP
    Mendell, JR
    King, WM
    Pandya, S
    Griggs, RC
    Tawil, R
    Cos, L
    Langsam, A
    Martens, B
    Brower, C
    Herr, BE
    Figlewicz, D
    Forrester, J
    Downing, K
    Holloway, RG
    Hubble, J
    Kolassa, J
    [J]. NEUROLOGY, 2001, 57 (08) : 1434 - 1440
  • [18] Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates
    Kota, Janaiah
    Handy, Chalonda R.
    Haidet, Amanda M.
    Montgomery, Chrystal L.
    Eagle, Amy
    Rodino-Klapac, Louise R.
    Tucker, Danielle
    Shilling, Christopher J.
    Therlfall, Walter R.
    Walker, Christopher M.
    Weisbrode, Steven E.
    Janssen, Paul M. L.
    Clark, K. Reed
    Sahenk, Zarife
    Mendell, Jerry R.
    Kaspar, Brian K.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2009, 1 (06)
  • [19] Anti-T-lymphocyte globulin treatment in inclusion body myositis - A randomized pilot study
    Lindberg, C
    Trysberg, E
    Tarkowski, A
    Oldfors, A
    [J]. NEUROLOGY, 2003, 61 (02) : 260 - 262
  • [20] Glucocorticoid corticosteroids for Duchenne muscular dystrophy
    Manzur, A. Y.
    Kuntzer, T.
    Pike, M.
    Swan, A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):